[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Recombinant Monoclonal Antibody Supply, Demand and Key Producers, 2024-2030

February 2024 | 112 pages | ID: G4A90903BFDAEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Recombinant Monoclonal Antibody market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

This report studies the global Recombinant Monoclonal Antibody production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Recombinant Monoclonal Antibody, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Recombinant Monoclonal Antibody that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Recombinant Monoclonal Antibody total production and demand, 2019-2030, (K Units)

Global Recombinant Monoclonal Antibody total production value, 2019-2030, (USD Million)

Global Recombinant Monoclonal Antibody production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)

Global Recombinant Monoclonal Antibody consumption by region & country, CAGR, 2019-2030 & (K Units)

U.S. VS China: Recombinant Monoclonal Antibody domestic production, consumption, key domestic manufacturers and share

Global Recombinant Monoclonal Antibody production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)

Global Recombinant Monoclonal Antibody production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)

Global Recombinant Monoclonal Antibody production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Recombinant Monoclonal Antibody market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, Boster Bio, Evitria, Novus Biologicals, ACROBiosystems, Abyntek Biopharma, Sino Biological and Enzo Life Sciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Recombinant Monoclonal Antibody market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Recombinant Monoclonal Antibody Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Recombinant Monoclonal Antibody Market, Segmentation by Type
  • Humanized Antibodies
  • Small Molecule Antibody
  • Other
Global Recombinant Monoclonal Antibody Market, Segmentation by Application
  • Immunohistochemistry
  • Western Blot
  • Immunofluorescence
  • Other
Companies Profiled:
  • Abcam
  • Boster Bio
  • Evitria
  • Novus Biologicals
  • ACROBiosystems
  • Abyntek Biopharma
  • Sino Biological
  • Enzo Life Sciences
Key Questions Answered

1. How big is the global Recombinant Monoclonal Antibody market?

2. What is the demand of the global Recombinant Monoclonal Antibody market?

3. What is the year over year growth of the global Recombinant Monoclonal Antibody market?

4. What is the production and production value of the global Recombinant Monoclonal Antibody market?

5. Who are the key producers in the global Recombinant Monoclonal Antibody market?
1 SUPPLY SUMMARY

1.1 Recombinant Monoclonal Antibody Introduction
1.2 World Recombinant Monoclonal Antibody Supply & Forecast
  1.2.1 World Recombinant Monoclonal Antibody Production Value (2019 & 2023 & 2030)
  1.2.2 World Recombinant Monoclonal Antibody Production (2019-2030)
  1.2.3 World Recombinant Monoclonal Antibody Pricing Trends (2019-2030)
1.3 World Recombinant Monoclonal Antibody Production by Region (Based on Production Site)
  1.3.1 World Recombinant Monoclonal Antibody Production Value by Region (2019-2030)
  1.3.2 World Recombinant Monoclonal Antibody Production by Region (2019-2030)
  1.3.3 World Recombinant Monoclonal Antibody Average Price by Region (2019-2030)
  1.3.4 North America Recombinant Monoclonal Antibody Production (2019-2030)
  1.3.5 Europe Recombinant Monoclonal Antibody Production (2019-2030)
  1.3.6 China Recombinant Monoclonal Antibody Production (2019-2030)
  1.3.7 Japan Recombinant Monoclonal Antibody Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Recombinant Monoclonal Antibody Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Recombinant Monoclonal Antibody Major Market Trends

2 DEMAND SUMMARY

2.1 World Recombinant Monoclonal Antibody Demand (2019-2030)
2.2 World Recombinant Monoclonal Antibody Consumption by Region
  2.2.1 World Recombinant Monoclonal Antibody Consumption by Region (2019-2024)
  2.2.2 World Recombinant Monoclonal Antibody Consumption Forecast by Region (2025-2030)
2.3 United States Recombinant Monoclonal Antibody Consumption (2019-2030)
2.4 China Recombinant Monoclonal Antibody Consumption (2019-2030)
2.5 Europe Recombinant Monoclonal Antibody Consumption (2019-2030)
2.6 Japan Recombinant Monoclonal Antibody Consumption (2019-2030)
2.7 South Korea Recombinant Monoclonal Antibody Consumption (2019-2030)
2.8 ASEAN Recombinant Monoclonal Antibody Consumption (2019-2030)
2.9 India Recombinant Monoclonal Antibody Consumption (2019-2030)

3 WORLD RECOMBINANT MONOCLONAL ANTIBODY MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Recombinant Monoclonal Antibody Production Value by Manufacturer (2019-2024)
3.2 World Recombinant Monoclonal Antibody Production by Manufacturer (2019-2024)
3.3 World Recombinant Monoclonal Antibody Average Price by Manufacturer (2019-2024)
3.4 Recombinant Monoclonal Antibody Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Recombinant Monoclonal Antibody Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Recombinant Monoclonal Antibody in 2023
  3.5.3 Global Concentration Ratios (CR8) for Recombinant Monoclonal Antibody in 2023
3.6 Recombinant Monoclonal Antibody Market: Overall Company Footprint Analysis
  3.6.1 Recombinant Monoclonal Antibody Market: Region Footprint
  3.6.2 Recombinant Monoclonal Antibody Market: Company Product Type Footprint
  3.6.3 Recombinant Monoclonal Antibody Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Recombinant Monoclonal Antibody Production Value Comparison
  4.1.1 United States VS China: Recombinant Monoclonal Antibody Production Value Comparison (2019 & 2023 & 2030)
  4.1.2 United States VS China: Recombinant Monoclonal Antibody Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Recombinant Monoclonal Antibody Production Comparison
  4.2.1 United States VS China: Recombinant Monoclonal Antibody Production Comparison (2019 & 2023 & 2030)
  4.2.2 United States VS China: Recombinant Monoclonal Antibody Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Recombinant Monoclonal Antibody Consumption Comparison
  4.3.1 United States VS China: Recombinant Monoclonal Antibody Consumption Comparison (2019 & 2023 & 2030)
  4.3.2 United States VS China: Recombinant Monoclonal Antibody Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Recombinant Monoclonal Antibody Manufacturers and Market Share, 2019-2024
  4.4.1 United States Based Recombinant Monoclonal Antibody Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Recombinant Monoclonal Antibody Production Value (2019-2024)
  4.4.3 United States Based Manufacturers Recombinant Monoclonal Antibody Production (2019-2024)
4.5 China Based Recombinant Monoclonal Antibody Manufacturers and Market Share
  4.5.1 China Based Recombinant Monoclonal Antibody Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Recombinant Monoclonal Antibody Production Value (2019-2024)
  4.5.3 China Based Manufacturers Recombinant Monoclonal Antibody Production (2019-2024)
4.6 Rest of World Based Recombinant Monoclonal Antibody Manufacturers and Market Share, 2019-2024
  4.6.1 Rest of World Based Recombinant Monoclonal Antibody Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Recombinant Monoclonal Antibody Production Value (2019-2024)
  4.6.3 Rest of World Based Manufacturers Recombinant Monoclonal Antibody Production (2019-2024)

5 MARKET ANALYSIS BY TYPE

5.1 World Recombinant Monoclonal Antibody Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
  5.2.1 Humanized Antibodies
  5.2.2 Small Molecule Antibody
  5.2.3 Other
5.3 Market Segment by Type
  5.3.1 World Recombinant Monoclonal Antibody Production by Type (2019-2030)
  5.3.2 World Recombinant Monoclonal Antibody Production Value by Type (2019-2030)
  5.3.3 World Recombinant Monoclonal Antibody Average Price by Type (2019-2030)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Recombinant Monoclonal Antibody Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
  6.2.1 Immunohistochemistry
  6.2.2 Western Blot
  6.2.3 Immunofluorescence
  6.2.4 Other
6.3 Market Segment by Application
  6.3.1 World Recombinant Monoclonal Antibody Production by Application (2019-2030)
  6.3.2 World Recombinant Monoclonal Antibody Production Value by Application (2019-2030)
  6.3.3 World Recombinant Monoclonal Antibody Average Price by Application (2019-2030)

7 COMPANY PROFILES

7.1 Abcam
  7.1.1 Abcam Details
  7.1.2 Abcam Major Business
  7.1.3 Abcam Recombinant Monoclonal Antibody Product and Services
  7.1.4 Abcam Recombinant Monoclonal Antibody Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.1.5 Abcam Recent Developments/Updates
  7.1.6 Abcam Competitive Strengths & Weaknesses
7.2 Boster Bio
  7.2.1 Boster Bio Details
  7.2.2 Boster Bio Major Business
  7.2.3 Boster Bio Recombinant Monoclonal Antibody Product and Services
  7.2.4 Boster Bio Recombinant Monoclonal Antibody Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.2.5 Boster Bio Recent Developments/Updates
  7.2.6 Boster Bio Competitive Strengths & Weaknesses
7.3 Evitria
  7.3.1 Evitria Details
  7.3.2 Evitria Major Business
  7.3.3 Evitria Recombinant Monoclonal Antibody Product and Services
  7.3.4 Evitria Recombinant Monoclonal Antibody Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.3.5 Evitria Recent Developments/Updates
  7.3.6 Evitria Competitive Strengths & Weaknesses
7.4 Novus Biologicals
  7.4.1 Novus Biologicals Details
  7.4.2 Novus Biologicals Major Business
  7.4.3 Novus Biologicals Recombinant Monoclonal Antibody Product and Services
  7.4.4 Novus Biologicals Recombinant Monoclonal Antibody Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.4.5 Novus Biologicals Recent Developments/Updates
  7.4.6 Novus Biologicals Competitive Strengths & Weaknesses
7.5 ACROBiosystems
  7.5.1 ACROBiosystems Details
  7.5.2 ACROBiosystems Major Business
  7.5.3 ACROBiosystems Recombinant Monoclonal Antibody Product and Services
  7.5.4 ACROBiosystems Recombinant Monoclonal Antibody Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.5.5 ACROBiosystems Recent Developments/Updates
  7.5.6 ACROBiosystems Competitive Strengths & Weaknesses
7.6 Abyntek Biopharma
  7.6.1 Abyntek Biopharma Details
  7.6.2 Abyntek Biopharma Major Business
  7.6.3 Abyntek Biopharma Recombinant Monoclonal Antibody Product and Services
  7.6.4 Abyntek Biopharma Recombinant Monoclonal Antibody Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.6.5 Abyntek Biopharma Recent Developments/Updates
  7.6.6 Abyntek Biopharma Competitive Strengths & Weaknesses
7.7 Sino Biological
  7.7.1 Sino Biological Details
  7.7.2 Sino Biological Major Business
  7.7.3 Sino Biological Recombinant Monoclonal Antibody Product and Services
  7.7.4 Sino Biological Recombinant Monoclonal Antibody Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.7.5 Sino Biological Recent Developments/Updates
  7.7.6 Sino Biological Competitive Strengths & Weaknesses
7.8 Enzo Life Sciences
  7.8.1 Enzo Life Sciences Details
  7.8.2 Enzo Life Sciences Major Business
  7.8.3 Enzo Life Sciences Recombinant Monoclonal Antibody Product and Services
  7.8.4 Enzo Life Sciences Recombinant Monoclonal Antibody Production, Price, Value, Gross Margin and Market Share (2019-2024)
  7.8.5 Enzo Life Sciences Recent Developments/Updates
  7.8.6 Enzo Life Sciences Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Recombinant Monoclonal Antibody Industry Chain
8.2 Recombinant Monoclonal Antibody Upstream Analysis
  8.2.1 Recombinant Monoclonal Antibody Core Raw Materials
  8.2.2 Main Manufacturers of Recombinant Monoclonal Antibody Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Recombinant Monoclonal Antibody Production Mode
8.6 Recombinant Monoclonal Antibody Procurement Model
8.7 Recombinant Monoclonal Antibody Industry Sales Model and Sales Channels
  8.7.1 Recombinant Monoclonal Antibody Sales Model
  8.7.2 Recombinant Monoclonal Antibody Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Recombinant Monoclonal Antibody Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Recombinant Monoclonal Antibody Production Value by Region (2019-2024) & (USD Million)
Table 3. World Recombinant Monoclonal Antibody Production Value by Region (2025-2030) & (USD Million)
Table 4. World Recombinant Monoclonal Antibody Production Value Market Share by Region (2019-2024)
Table 5. World Recombinant Monoclonal Antibody Production Value Market Share by Region (2025-2030)
Table 6. World Recombinant Monoclonal Antibody Production by Region (2019-2024) & (K Units)
Table 7. World Recombinant Monoclonal Antibody Production by Region (2025-2030) & (K Units)
Table 8. World Recombinant Monoclonal Antibody Production Market Share by Region (2019-2024)
Table 9. World Recombinant Monoclonal Antibody Production Market Share by Region (2025-2030)
Table 10. World Recombinant Monoclonal Antibody Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Recombinant Monoclonal Antibody Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Recombinant Monoclonal Antibody Major Market Trends
Table 13. World Recombinant Monoclonal Antibody Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Recombinant Monoclonal Antibody Consumption by Region (2019-2024) & (K Units)
Table 15. World Recombinant Monoclonal Antibody Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Recombinant Monoclonal Antibody Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Recombinant Monoclonal Antibody Producers in 2023
Table 18. World Recombinant Monoclonal Antibody Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Recombinant Monoclonal Antibody Producers in 2023
Table 20. World Recombinant Monoclonal Antibody Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Recombinant Monoclonal Antibody Company Evaluation Quadrant
Table 22. World Recombinant Monoclonal Antibody Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Recombinant Monoclonal Antibody Production Site of Key Manufacturer
Table 24. Recombinant Monoclonal Antibody Market: Company Product Type Footprint
Table 25. Recombinant Monoclonal Antibody Market: Company Product Application Footprint
Table 26. Recombinant Monoclonal Antibody Competitive Factors
Table 27. Recombinant Monoclonal Antibody New Entrant and Capacity Expansion Plans
Table 28. Recombinant Monoclonal Antibody Mergers & Acquisitions Activity
Table 29. United States VS China Recombinant Monoclonal Antibody Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Recombinant Monoclonal Antibody Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Recombinant Monoclonal Antibody Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Recombinant Monoclonal Antibody Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Recombinant Monoclonal Antibody Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Recombinant Monoclonal Antibody Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Recombinant Monoclonal Antibody Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Recombinant Monoclonal Antibody Production Market Share (2019-2024)
Table 37. China Based Recombinant Monoclonal Antibody Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Recombinant Monoclonal Antibody Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Recombinant Monoclonal Antibody Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Recombinant Monoclonal Antibody Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Recombinant Monoclonal Antibody Production Market Share (2019-2024)
Table 42. Rest of World Based Recombinant Monoclonal Antibody Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Recombinant Monoclonal Antibody Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Recombinant Monoclonal Antibody Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Recombinant Monoclonal Antibody Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Recombinant Monoclonal Antibody Production Market Share (2019-2024)
Table 47. World Recombinant Monoclonal Antibody Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Recombinant Monoclonal Antibody Production by Type (2019-2024) & (K Units)
Table 49. World Recombinant Monoclonal Antibody Production by Type (2025-2030) & (K Units)
Table 50. World Recombinant Monoclonal Antibody Production Value by Type (2019-2024) & (USD Million)
Table 51. World Recombinant Monoclonal Antibody Production Value by Type (2025-2030) & (USD Million)
Table 52. World Recombinant Monoclonal Antibody Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Recombinant Monoclonal Antibody Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Recombinant Monoclonal Antibody Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Recombinant Monoclonal Antibody Production by Application (2019-2024) & (K Units)
Table 56. World Recombinant Monoclonal Antibody Production by Application (2025-2030) & (K Units)
Table 57. World Recombinant Monoclonal Antibody Production Value by Application (2019-2024) & (USD Million)
Table 58. World Recombinant Monoclonal Antibody Production Value by Application (2025-2030) & (USD Million)
Table 59. World Recombinant Monoclonal Antibody Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Recombinant Monoclonal Antibody Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Abcam Basic Information, Manufacturing Base and Competitors
Table 62. Abcam Major Business
Table 63. Abcam Recombinant Monoclonal Antibody Product and Services
Table 64. Abcam Recombinant Monoclonal Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Abcam Recent Developments/Updates
Table 66. Abcam Competitive Strengths & Weaknesses
Table 67. Boster Bio Basic Information, Manufacturing Base and Competitors
Table 68. Boster Bio Major Business
Table 69. Boster Bio Recombinant Monoclonal Antibody Product and Services
Table 70. Boster Bio Recombinant Monoclonal Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Boster Bio Recent Developments/Updates
Table 72. Boster Bio Competitive Strengths & Weaknesses
Table 73. Evitria Basic Information, Manufacturing Base and Competitors
Table 74. Evitria Major Business
Table 75. Evitria Recombinant Monoclonal Antibody Product and Services
Table 76. Evitria Recombinant Monoclonal Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Evitria Recent Developments/Updates
Table 78. Evitria Competitive Strengths & Weaknesses
Table 79. Novus Biologicals Basic Information, Manufacturing Base and Competitors
Table 80. Novus Biologicals Major Business
Table 81. Novus Biologicals Recombinant Monoclonal Antibody Product and Services
Table 82. Novus Biologicals Recombinant Monoclonal Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Novus Biologicals Recent Developments/Updates
Table 84. Novus Biologicals Competitive Strengths & Weaknesses
Table 85. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 86. ACROBiosystems Major Business
Table 87. ACROBiosystems Recombinant Monoclonal Antibody Product and Services
Table 88. ACROBiosystems Recombinant Monoclonal Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. ACROBiosystems Recent Developments/Updates
Table 90. ACROBiosystems Competitive Strengths & Weaknesses
Table 91. Abyntek Biopharma Basic Information, Manufacturing Base and Competitors
Table 92. Abyntek Biopharma Major Business
Table 93. Abyntek Biopharma Recombinant Monoclonal Antibody Product and Services
Table 94. Abyntek Biopharma Recombinant Monoclonal Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Abyntek Biopharma Recent Developments/Updates
Table 96. Abyntek Biopharma Competitive Strengths & Weaknesses
Table 97. Sino Biological Basic Information, Manufacturing Base and Competitors
Table 98. Sino Biological Major Business
Table 99. Sino Biological Recombinant Monoclonal Antibody Product and Services
Table 100. Sino Biological Recombinant Monoclonal Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Sino Biological Recent Developments/Updates
Table 102. Enzo Life Sciences Basic Information, Manufacturing Base and Competitors
Table 103. Enzo Life Sciences Major Business
Table 104. Enzo Life Sciences Recombinant Monoclonal Antibody Product and Services
Table 105. Enzo Life Sciences Recombinant Monoclonal Antibody Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 106. Global Key Players of Recombinant Monoclonal Antibody Upstream (Raw Materials)
Table 107. Recombinant Monoclonal Antibody Typical Customers
Table 108. Recombinant Monoclonal Antibody Typical Distributors

LIST OF FIGURE

Figure 1. Recombinant Monoclonal Antibody Picture
Figure 2. World Recombinant Monoclonal Antibody Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Recombinant Monoclonal Antibody Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Recombinant Monoclonal Antibody Production (2019-2030) & (K Units)
Figure 5. World Recombinant Monoclonal Antibody Average Price (2019-2030) & (US$/Unit)
Figure 6. World Recombinant Monoclonal Antibody Production Value Market Share by Region (2019-2030)
Figure 7. World Recombinant Monoclonal Antibody Production Market Share by Region (2019-2030)
Figure 8. North America Recombinant Monoclonal Antibody Production (2019-2030) & (K Units)
Figure 9. Europe Recombinant Monoclonal Antibody Production (2019-2030) & (K Units)
Figure 10. China Recombinant Monoclonal Antibody Production (2019-2030) & (K Units)
Figure 11. Japan Recombinant Monoclonal Antibody Production (2019-2030) & (K Units)
Figure 12. Recombinant Monoclonal Antibody Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Recombinant Monoclonal Antibody Consumption (2019-2030) & (K Units)
Figure 15. World Recombinant Monoclonal Antibody Consumption Market Share by Region (2019-2030)
Figure 16. United States Recombinant Monoclonal Antibody Consumption (2019-2030) & (K Units)
Figure 17. China Recombinant Monoclonal Antibody Consumption (2019-2030) & (K Units)
Figure 18. Europe Recombinant Monoclonal Antibody Consumption (2019-2030) & (K Units)
Figure 19. Japan Recombinant Monoclonal Antibody Consumption (2019-2030) & (K Units)
Figure 20. South Korea Recombinant Monoclonal Antibody Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Recombinant Monoclonal Antibody Consumption (2019-2030) & (K Units)
Figure 22. India Recombinant Monoclonal Antibody Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Recombinant Monoclonal Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Recombinant Monoclonal Antibody Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Recombinant Monoclonal Antibody Markets in 2023
Figure 26. United States VS China: Recombinant Monoclonal Antibody Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Recombinant Monoclonal Antibody Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Recombinant Monoclonal Antibody Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Recombinant Monoclonal Antibody Production Market Share 2023
Figure 30. China Based Manufacturers Recombinant Monoclonal Antibody Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Recombinant Monoclonal Antibody Production Market Share 2023
Figure 32. World Recombinant Monoclonal Antibody Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Recombinant Monoclonal Antibody Production Value Market Share by Type in 2023
Figure 34. Humanized Antibodies
Figure 35. Small Molecule Antibody
Figure 36. Other
Figure 37. World Recombinant Monoclonal Antibody Production Market Share by Type (2019-2030)
Figure 38. World Recombinant Monoclonal Antibody Production Value Market Share by Type (2019-2030)
Figure 39. World Recombinant Monoclonal Antibody Average Price by Type (2019-2030) & (US$/Unit)
Figure 40. World Recombinant Monoclonal Antibody Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 41. World Recombinant Monoclonal Antibody Production Value Market Share by Application in 2023
Figure 42. Immunohistochemistry
Figure 43. Western Blot
Figure 44. Immunofluorescence
Figure 45. Other
Figure 46. World Recombinant Monoclonal Antibody Production Market Share by Application (2019-2030)
Figure 47. World Recombinant Monoclonal Antibody Production Value Market Share by Application (2019-2030)
Figure 48. World Recombinant Monoclonal Antibody Average Price by Application (2019-2030) & (US$/Unit)
Figure 49. Recombinant Monoclonal Antibody Industry Chain
Figure 50. Recombinant Monoclonal Antibody Procurement Model
Figure 51. Recombinant Monoclonal Antibody Sales Model
Figure 52. Recombinant Monoclonal Antibody Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source


More Publications